Single center experience of 90Y-Ibritumomab tiuxetan in the older population with non-hodgkin lymphoma.

被引：0
作者：
Agrawal, Vaibhav [1 ]
Castillo, Jose Isaac [1 ]
Raup, Kelly [1 ]
Girton, Treanna [1 ]
Collins, Scott R. [1 ]
Brady, James O. [1 ]
Khan, Sharif S. [1 ]
Vadakara, Joseph [1 ]
机构：
[1] Geisinger Med Ctr, Danville, PA 17822 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e19035
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19035
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Single institution experience with y-90 lbriturnomab tiuxetan in the treatment of non-Hodgkin lymphoma.
    Martin, Peter
    Michel, Rene
    Galal, Ahmed
    [J]. BLOOD, 2006, 108 (11) : 257B - 257B
  • [12] JUT with 90Y Ibritumomab Tiuxetan in Agressive Non-Hodgkin Lymphoma. Evaluation of Recent Outcomes in a Single Institution
    Montes, Anel
    Andrade, Ma
    Murillo, Ilda
    Lopez-Gomez, Luis
    Baringo, Teresa
    Giraldo, Pilar
    [J]. BLOOD, 2012, 120 (21)
  • [13] Diagnostic imaging prior to 90Y-ibritumomab tiuxetan (Zevalin®) treatment in follicular non-Hodgkin's lymphoma
    Otte, Andreas
    [J]. HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2008, 11 (01): : 12 - 15
  • [14] 90Y-IBRITUMOMAB TIUXETAN TREATMENT FOR RELAPSED AND/OR REFRACTORY B CELL NON-HODGKIN'S LYMPHOMA. MULTI-INSTITUTIONAL ARGENTINIAN STUDY
    Cacchione, R.
    Milone, J.
    Nucifora, E.
    Bordone, J.
    Dupont, J.
    Rudoy, S.
    Brown, M.
    Lafalce, D.
    Palmer, L.
    Argentieri, D.
    Negri, P.
    Bartomioli, M.
    Milone, G.
    Trouboul, A.
    Ardaiz, M.
    Iabstrebner, M.
    Pombo, G.
    Basso, A.
    Diaz, A.
    Tur, R.
    Saidon, G.
    Krupitzki, H.
    Garay, G.
    Riveros, D.
    Carrasco, A.
    Chiattone, C.
    Bezares, E.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 109 - 109
  • [15] Radioimmunotherapy with 90Y-Zevalin (90y-Ibritumomab Tiuxetan) in Patients with Non Hodgkin Lymphoma: Preliminary Experience of our Centre
    Vallejos, V.
    Calvo, E.
    Xicoy, B.
    Riba, J.
    Rubio, A.
    Sola, M.
    Mila, M.
    Rosado, M.
    Ribera, J. M.
    Fraile, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S352 - S353
  • [16] 90Y-Ibritumomab Tiuxetan as Consolidation Therapy After Autologous Stem Cell Transplantation in Aggressive Non-Hodgkin Lymphoma
    Ria, Roberto
    Musto, Pellegrino
    Reale, Antonia
    Guariglia, Roberto
    Iodice, Giuseppe
    Dammacco, Franco
    Vacca, Angelo
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2011, 52 (06) : 891 - 895
  • [17] Therapeutic efficacy and toxicity of 90Y-Ibritumomab tiuxetan in patients with B-Cell non-Hodgkin's lymphoma
    Boni, G.
    Lorenzoni, A.
    Galimberti, S.
    Cecconi, N.
    Genovesi, D.
    Grosso, M.
    Ciuti, S.
    Petrini, M.
    Mariani, G.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S169 - S169
  • [18] Initial experience with rituximab and 90Y-ibritumomab tiuxetan for the treatment of mature B-cell lymphoma.
    Al-Shemmari, Salem H.
    Al-Mohannadi, Shihab M.
    Khan, Haider A.
    Sajnani, Kamlesh P.
    [J]. BLOOD, 2006, 108 (11) : 266B - 267B
  • [19] B-Cell non-Hodgkin lymphoma:: PET/CT evaluation after 90Y-ibritumomab tiuxetan radioimmunotherapy-initial experience
    Ulaner, Gary A.
    Colletti, Patrick M.
    Conti, Peter S.
    [J]. RADIOLOGY, 2008, 246 (03) : 895 - 902
  • [20] Radioimmunotherapy with 90Y Ibritumomab Tiuxetan in patients with relapsed or refractory B-cell non-Hodgkin lymphoma.
    Palumbo, B.
    Sabalich, I.
    Falcinelli, F.
    Capponi, M.
    Martelli, M.
    Palumbo, R.
    Sinzinger, H.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S419 - S419
12345